{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:46:24Z","timestamp":1760150784081,"version":"build-2065373602"},"reference-count":55,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003000","name":"Stichting Het Remmert Adriaan Laan Fonds and the Dutch MS Research Foundation","doi-asserted-by":"publisher","award":["14-358e"],"award-info":[{"award-number":["14-358e"]}],"id":[{"id":"10.13039\/501100003000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Background: The glymphatic system removes neurodegenerative debris. The ocular glymphatic outflow is from the eye to the proximal optic nerve. In multiple sclerosis (MS), atrophy of the optic nerve increases the glymphatic outflow space. Here, we tested whether vitreous haze (VH) can provide novel insights into the relationship between neurodegeneration and the ocular glymphatic system in MS. Methods: This cross-sectional study comprised 315 persons with MS and 87 healthy controls (HCs). VH was quantified from optical coherence tomography (OCT) volume scans. Neurodegeneration was determined on three-dimensional T1 (3DT1) MRI, lesion detection on fluid-attenuated inversion (FLAIR), and layer thickness on OCT. Generalized estimating equations, corrected for age, were used to analyze associations between VH and metrics for neurodegeneration, demographics, and clinical scales. Group differences were determined between mild, moderate, and severe disability. Results: On the group level, VH scores were comparable between MS and control (p = 0.629). In MS, VH scores declined with disease duration (\u03b2 = \u22120.009, p = 0.004) and age (\u03b2 = \u22120.007, p = 0.001). There was no relation between VH scores and higher age in HCs. In MS patients, VH was related to normalized gray (NGMV, \u03b2 = 0.001, p = 0.011) and white matter volume (NWMV, \u03b2 = 0.001, p = 0.003), macular ganglion cell\u2013inner plexiform layer thickness (mGCIPL, \u03b2 = 0.006, p &lt; 0.001), and peripapillary retinal nerve fiber layer thickness (pRNFL, \u03b2 = 0.004, p = 0.008). VH was significantly lower in severe compared to mild disability (mean difference \u221228.86%, p = 0.058). Conclusions: There is a correlation between VH on OCT and disease duration, more severe disability and lower brain volumes in MS. Biologically, these relationships suggest accelerated glymphatic clearance with disease-related atrophy.<\/jats:p>","DOI":"10.3390\/brainsci14010036","type":"journal-article","created":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T06:00:21Z","timestamp":1704002421000},"page":"36","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring Vitreous Haze as a Potential Biomarker for Accelerated Glymphatic Outflow and Neurodegeneration in Multiple Sclerosis: A Cross-Sectional Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6695-2667","authenticated-orcid":false,"given":"Sezgi","family":"Ka\u00e7ar","sequence":"first","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC Location VUmc, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"},{"name":"Dutch Expertise Center for Neuro-Ophthalmology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danko","family":"Coric","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC Location VUmc, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"},{"name":"Dutch Expertise Center for Neuro-Ophthalmology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Ometto","sequence":"additional","affiliation":[{"name":"Department of Optometry and Visual Sciences, City, University of London, London WC1E 7HU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Montesano","sequence":"additional","affiliation":[{"name":"Department of Optometry and Visual Sciences, City, University of London, London WC1E 7HU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair K.","family":"Denniston","sequence":"additional","affiliation":[{"name":"Academic Unit of Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham B15 2TT, UK"},{"name":"Department of Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TT, UK"},{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital and UCL Institute of Ophthalmology, London EC1V 9LF, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital and UCL Institute of Ophthalmology, London EC1V 9LF, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard M. J.","family":"Uitdehaag","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC Location VUmc, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Crabb","sequence":"additional","affiliation":[{"name":"Department of Optometry and Visual Sciences, City, University of London, London WC1E 7HU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menno M.","family":"Schoonheim","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Neurosciences, Neuroscience Campus Amsterdam, VU University Medical Center, 1081 HV Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0344-9749","authenticated-orcid":false,"given":"Axel","family":"Petzold","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC Location VUmc, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"},{"name":"Dutch Expertise Center for Neuro-Ophthalmology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands"},{"name":"Department of Neurology and Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 9LF, UK"},{"name":"The National Hospital for Neurology and Neurosurgery, University College London, London WC1E 7HU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6705-5864","authenticated-orcid":false,"given":"Eva M. M.","family":"Strijbis","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, VU University Medical Center, Amsterdam UMC Location VUmc, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000360528","article-title":"Multiple sclerosis: Current knowledge and future outlook","volume":"72","author":"Kamm","year":"2014","journal-title":"Eur. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclerosis: Clinical aspects","volume":"31","author":"Oh","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-52001-2.00005-4","article-title":"Chapter 5\u2014Axonal loss in multiple sclerosis: Causes and mechanisms","volume":"Volume 122","author":"Goodin","year":"2014","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/1352458516686847","article-title":"Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop","volume":"24","author":"Amato","year":"2018","journal-title":"Mult. Scler. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_7","unstructured":"Rich, R.R., Fleisher, T.A., Shearer, W.T., Schroeder, H.W., Frew, A.J., and Weyand, C.M. (2019). Clinical Immunology, Elsevier. [5th ed.]."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13317-019-0117-5","article-title":"Brain atrophy in multiple sclerosis: Mechanisms, clinical relevance and treatment options","volume":"10","author":"Andravizou","year":"2019","journal-title":"Autoimmun. Highlights"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1586\/14737159.2013.850033","article-title":"Molecular biomarkers of neurodegeneration","volume":"13","author":"Salter","year":"2013","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour\u2014Targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41583-021-00454-8","article-title":"Molecular mechanisms of brain water transport","volume":"22","author":"MacAulay","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/WNL.0000000000006166","article-title":"Idiopathic intracranial hypertension: The veno glymphatic connections","volume":"91","author":"Lenck","year":"2018","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders","volume":"17","author":"Rasmussen","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/brain\/awab454","article-title":"Glymphatic system impairment in multiple sclerosis: Relation with brain damage and disability","volume":"145","author":"Carotenuto","year":"2022","journal-title":"Brain"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Verghese, J.P., Terry, A., de Natale, E.R., and Politis, M. (2022). Research Evidence of the Role of the Glymphatic System and Its Potential Pharmacological Modulation in Neurodegenerative Diseases. J. Clin. Med., 11.","DOI":"10.3390\/jcm11236964"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1167\/iovs.15-17243","article-title":"Paravascular Pathways in the Eye: Is There an \u2018Ocular Glymphatic System\u2019?","volume":"56","author":"Denniston","year":"2015","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1007\/s00018-016-2348-1","article-title":"Age-related macular degeneration, glaucoma and Alzheimer\u2019s disease: Amyloidogenic diseases with the same glymphatic background?","volume":"73","author":"Wostyn","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/brain\/aww239","article-title":"Retinal glymphatic system: An explanation for transient retinal layer volume changes?","volume":"139","author":"Petzold","year":"2016","journal-title":"Brain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"eaaw3210","DOI":"10.1126\/scitranslmed.aaw3210","article-title":"An ocular glymphatic clearance system removes &#x3b2;-amyloid from the rodent eye","volume":"12","author":"Wang","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41598-018-20092-y","article-title":"Optimizing OCT acquisition parameters for assessments of vitreous haze for application in uveitis","volume":"8","author":"Montesano","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.11.1.3","article-title":"OCT Assisted Quantification of Vitreous Inflammation in Uveitis","volume":"11","author":"Liu","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"144-e3","DOI":"10.1111\/ene.14048","article-title":"Objective quantification of vitreous haze on optical coherence tomography scans: No evidence for relationship between uveitis and inflammation in multiple sclerosis","volume":"27","author":"Coric","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/13524585211010097","article-title":"Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis","volume":"28","author":"Wieske","year":"2022","journal-title":"Mult. Scler."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrneurol.2014.108","article-title":"The investigation of acute optic neuritis: A review and proposed protocol","volume":"10","author":"Petzold","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1167\/iovs.11-8209","article-title":"The physiological variation of the retinal nerve fiber layer thickness and macular volume in humans as assessed by spectral domain-optical coherence tomography","volume":"53","author":"Balk","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1212\/WNL.0000000000012125","article-title":"APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies","volume":"97","author":"Aytulun","year":"2021","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Tewarie, P., Balk, L., Costello, F., Green, A., Martin, R., Schippling, S., and Petzold, A. (2012). The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034823"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.4.5.4","article-title":"Automated Analysis of Vitreous Inflammation Using Spectral-Domain Optical Coherence Tomography","volume":"4","author":"Keane","year":"2015","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/jnnp-2013-306902","article-title":"A dam for retrograde axonal degeneration in multiple sclerosis?","volume":"85","author":"Balk","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jnnp-2014-308189","article-title":"Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis","volume":"86","author":"Balk","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.nicl.2013.10.003","article-title":"Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs)","volume":"3","author":"Steenwijk","year":"2013","journal-title":"Neuroimage Clin."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jmri.22214","article-title":"Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes","volume":"32","author":"Chard","year":"2010","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/1352458517699874","article-title":"Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment","volume":"24","author":"Leurs","year":"2018","journal-title":"Mult. Scler."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"104987","DOI":"10.1016\/j.isci.2022.104987","article-title":"The glymphatic system: Current understanding and modeling","volume":"25","author":"Bohr","year":"2022","journal-title":"iScience"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Buccellato, F.R., D\u2019Anca, M., Serpente, M., Arighi, A., and Galimberti, D. (2022). The Role of Glymphatic System in Alzheimer&rsquo;s and Parkinson&rsquo;s Disease Pathogenesis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092261"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/brain\/awq360","article-title":"In vivo monitoring of neuronal loss in traumatic brain injury: A microdialysis study","volume":"134","author":"Petzold","year":"2011","journal-title":"Brain"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1474-4422(17)30278-8","article-title":"Retinal layer segmentation in multiple sclerosis: A systematic review and meta-analysis","volume":"16","author":"Petzold","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00415-016-8127-y","article-title":"Timing of retinal neuronal and axonal loss in MS: A longitudinal OCT study","volume":"263","author":"Balk","year":"2016","journal-title":"J. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/acn3.51473","article-title":"Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study","volume":"8","author":"Paul","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The Glymphatic System: A Beginner\u2019s Guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bpa.12085","article-title":"Biology of AQP4 and anti-AQP4 antibody: Therapeutic implications for NMO","volume":"23","author":"Verkman","year":"2013","journal-title":"Brain Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Carare","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.25782","article-title":"Longitudinal Development of Peripapillary Hyper-Reflective Ovoid Masslike Structures Suggests a Novel Pathological Pathway in Multiple Sclerosis","volume":"88","author":"Petzold","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/glia.22477","article-title":"New functions of M\u00fcller cells","volume":"61","author":"Reichenbach","year":"2013","journal-title":"Glia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/qims.2019.11.18","article-title":"Quantitative imaging of the clearance systems in the eye and the brain","volume":"10","author":"Deng","year":"2019","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_49","unstructured":"Ann, L.A. (2012). Clinical Anatomy and Physiology of the Visual System, Elsevier."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/01658107.2022.2025852","article-title":"Upregulated Retinal Neurofilament Expression in Experimental Optic Neuritis","volume":"46","author":"Weissert","year":"2022","journal-title":"Neuroophthalmology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00702-009-0316-8","article-title":"A novel biomarker for retinal degeneration: Vitreous body neurofilament proteins","volume":"116","author":"Petzold","year":"2009","journal-title":"J. Neural. Transm."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Subramanian, I., Verma, S., Kumar, S., Jere, A., and Anamika, K. (2020). Multi-omics Data Integration, Interpretation, and Its Application. Bioinform. Biol. Insights, 14.","DOI":"10.1177\/1177932219899051"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/bjo-2021-320828","article-title":"Neurofilament light chain: A new marker for neuronal decay in the anterior chamber fluid of patients with glaucoma","volume":"107","author":"Woltsche","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/ana.26027","article-title":"Peripapillary Hyper-Reflective Ovoid Mass-Like Structures in Astronauts","volume":"89","author":"Wostyn","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e2207724119","DOI":"10.1073\/pnas.2207724119","article-title":"The effect of long-duration spaceflight on perivascular spaces within the brain","volume":"119","author":"Wostyn","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/14\/1\/36\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:44:44Z","timestamp":1760132684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/14\/1\/36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,30]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["brainsci14010036"],"URL":"https:\/\/doi.org\/10.3390\/brainsci14010036","relation":{},"ISSN":["2076-3425"],"issn-type":[{"type":"electronic","value":"2076-3425"}],"subject":[],"published":{"date-parts":[[2023,12,30]]}}}